Top White Papers and Webcasts

  • How life sciences companies can generate new insights about their therapies in action   The business of life sciences R&D is fundamentally shifting – from a primary focus on regulatory approval to a broader view on widespread adoption by providers and payers…  from showing the value of treatments in controlled, isolated clinical settings to proving it in large target populations and real world conditions.  The opportunity is at hand to gain insights from tens of thousands of …

  • Financial services organizations, including banks, brokers, insurance, and wealth management advisors, are subject to a number of regulations to govern data security, making these institutions subject to a great deal of scrutiny over their cybersecurity efforts. This regulatory scrutiny makes data breaches particularly costly. Data breaches can come from any number of sources, including mistakes from well-intended employees, rogue employees, and international crime organizations. Read this executive brief to …